| Financial Year |
March 31 2023 |
| Monetary Funds |
570,467,871.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,860,267,261.67 |
| Advances to Suppliers |
20,822,474.66 |
| Other Receivables |
123,660,596.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
347,722,479.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
303,322,089.95 |
| Other Current Assets |
54,477,276.71 |
| Total Current Assets |
4,122,630,759.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
58,238,289.37 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
839,096,688.07 |
| Under-construction Projects |
6,310,238.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
541,875,856.80 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
69,864,112.33 |
| Deferred Income Tax Assets |
84,842,295.01 |
| Other Non-Current Assets |
10,129,708.00 |
| Sub-Total of Non-Current Assets |
1,665,111,838.27 |
| Total Assets |
5,787,742,597.27 |
| Short-Term Loans |
141,645,151.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
296,649,427.26 |
| Accounts Payable |
845,466,131.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
254,053,030.44 |
| Taxes Payable |
79,355,632.31 |
| Interest Payable |
45,362.90 |
| Dividend Payable |
32,040,298.75 |
| Other payables |
223,714,860.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,267,819.24 |
| Other Current Liabilities |
4,028,874.33 |
| Sub-Total of Current Liabilities |
1,911,227,703.14 |
| Long-term Loans |
192,600,329.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,161,575.63 |
| Deferred Income Tax Liabilities |
8,406,986.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
269,077,726.66 |
| Total Liabilities |
2,180,305,429.80 |
| Paid-In Capital(Or Share Stock) |
415,655,737.00 |
| Capital Surplus |
847,200,614.65 |
| Surplus Reserve |
207,827,868.50 |
| LESS:Treasury Stock |
3,980,965.12 |
| Undistributed Profits |
1,780,560,384.17 |
| Minority Stockholder's Interest |
351,017,992.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,256,419,174.84 |
| Owner's Equity（Stockholder's Equity） |
3,607,437,167.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,787,742,597.27 |
